Why the world shouldn’t dismiss North Korea’s COVID-19 vaccine trials
North Korea's increased investment and emphasis on research means COVID-19 clinical trials might actually be underway
On July 18, North Korea announced that a domestically produced COVID-19 vaccine entered clinical trials, joining the global race to develop a cure for a virus that has already killed at least 650,000 people worldwide.
An otherwise quiet North Korean state website, Mirae, first published the report, which was then quickly picked up by South Korean media and even CNN. The New York Times went so far as to add the North Korean clinical trial to its vaccine tracker.
Nevertheless, news media was quick to stress doubt that the DPRK had the funds or expertise to develop
- 01How sanctions failed to stop North Korea from developing dangerous weapons tech
- 02‘Growing scope’ of North Korean nuclear weapons shown in unpublished UN report
- 03Photos: Shops, restaurants and Sinuiju port – a view from Dandong in July
- 04Timeline: From multiple Kim Jong Un appearances to defector ‘suspected’ of COVID
- 05Why Lee In-young may be the most vocal and successful unification minister yet
- 06North Korean ships spotted returning to old coal smuggling routes near Vietnam
- 07North Korea in July 2020: a month in review and what’s ahead
- 08North Korea’s first suspected COVID-19 case sparks joy and censorship in China